H. de Graaf

Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group

Marije E. Hamaker, Caroline Seynaeve, A.N.M. Wymenga et al. · The Breast · 2013 · 137 citations

Medicine, Geriatric Medicine, Oncology +17

A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG

Carolien H. Smorenburg, S.M. de Groot, A. Elise van Leeuwen‐Stok et al. · Annals of Oncology · 2014 · 63 citations · Full text

Medicine, Oncology, Pharmacology +11

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

A.K.L. Reyners, Linda de Munck, Frans Erdkamp et al. · Annals of Oncology · 2012 · 43 citations · Full text

Medicine, Oncology, Pharmacology +12

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Anna van der Voort, Fleur M. Louis, Mette S. van Ramshorst et al. · The Lancet Oncology · 2024 · 43 citations · Full text

Medicine, Oncology, Radiology +14

A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma

Filip De Vos, A.M.E. Bos, Michael Schaapveld et al. · Gynecologic Oncology · 2005 · 36 citations

Medicine, Oncology, Pharmacology +14